메뉴 건너뛰기
Medecine/Sciences
Volumn 23, Issue 2, 2007, Pages 127-129
Age-related macular degeneration: Therapeutic hopes;Espoirs thérapeutiques dans la dégénérescence maculaire liée à l'âge
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB;
EID: 33847167436     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2007232127     Document Type: Note
Times cited : (6)
References (10)
  • 1
    • 33749440219 scopus 로고    scopus 로고
    • Age-related macular degeneration
    • De Jong PT. Age-related macular degeneration. N Engl J Med 2006 ; 355 : 1474-85.
    • (2006) N Engl J Med , vol.355 , pp. 1474-1485
    • De Jong, P.T.1
  • 2
    • 20244388812 scopus 로고    scopus 로고
    • Complement factor H variant increases the risk of age-related macular degeneration
    • Haines JL, Hauser MA, Schmidts, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005 ; 308 : 418-21.
    • (2005) Science , vol.308 , pp. 418-421
    • Haines, J.L.1    Hauser, M.A.2    Schmidts3
  • 3
    • 20244380171 scopus 로고    scopus 로고
    • Complement factor H polymorphisms in age-related macular degeneration
    • Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphisms in age-related macular degeneration. Science 2005 ; 308 : 385-9.
    • (2005) Science , vol.308 , pp. 385-389
    • Klein, R.J.1    Zeiss, C.2    Chew, E.Y.3
  • 4
    • 33751004690 scopus 로고    scopus 로고
    • A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration
    • Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006 ; 314 : 992-3.
    • (2006) Science , vol.314 , pp. 992-993
    • Yang, Z.1    Camp, N.J.2    Sun, H.3
  • 5
    • 33751011889 scopus 로고    scopus 로고
    • HTRA1 promoter polymorphism in wet age-related macular degeneration
    • Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006 ; 314 : 989-92.
    • (2006) Science , vol.314 , pp. 989-992
    • Dewan, A.1    Liu, M.2    Hartman, S.3
  • 6
    • 34250192745 scopus 로고    scopus 로고
    • Treatment of age-related macular degeneration with photodynamic therapy. Verteporfin in photodynamic therapy study group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: Case reports from randomized clinical trials-TAP and VIP report no3
    • Arnold JJ, Blinder KJ, Bressler NM, et al. Treatment of age-related macular degeneration with photodynamic therapy. Verteporfin in photodynamic therapy study group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no3. Am J Ophthalmol 2004 ; 137 : 683-96.
    • (2004) Am J Ophthalmol , vol.137 , pp. 683-696
    • Arnold, J.J.1    Blinder, K.J.2    Bressler, N.M.3
  • 7
    • 0942268751 scopus 로고    scopus 로고
    • Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review
    • Meads C, Hyde C. Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review. Br J Ophthalmol 2004 ; 88 : 212-7.
    • (2004) Br J Ophthalmol , vol.88 , pp. 212-217
    • Meads, C.1    Hyde, C.2
  • 8
    • 32844458094 scopus 로고    scopus 로고
    • Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review
    • Kourlas H, Schiller DS. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review. Clin Ther 2006 ; 28 : 36-44.
    • (2006) Clin Ther , vol.28 , pp. 36-44
    • Kourlas, H.1    Schiller, D.S.2
  • 9
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • for the MARINA study group
    • Rosenfeld PJ, Brown DM, Heier JS, et al. for the MARINA study group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006 ; 335 : 1419-31.
    • (2006) N Engl J Med , vol.335 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 10
    • 33750575485 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): Results of a phase 1 dose-escalation study
    • Costa RA, Jorge R, Calucci D, et al. Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study. Invest Ophthalmol Vis Sci 2006 ; 47 : 4569-78.
    • (2006) Invest Ophthalmol Vis Sci , vol.47 , pp. 4569-4578
    • Costa, R.A.1    Jorge, R.2    Calucci, D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.